Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National Study of Adrenal Tumours

NCT06870396 is registered in ClinicalTrials.gov with Society for Endocrinology as lead sponsor.

NCT NCT06870396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06870396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National Study of Adrenal Tumours
Lead sponsor
Society for Endocrinology
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 15, 2025
Completion date
December 31, 2034
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal tumours, adrenocorticol cancer (acc), pheochromocytoma and paraganglioma (ppgl)